A. MAUREEN ROUHI

3.0k total citations
105 papers, 1.8k citations indexed

About

A. MAUREEN ROUHI is a scholar working on Molecular Biology, Environmental Chemistry and Cancer Research. According to data from OpenAlex, A. MAUREEN ROUHI has authored 105 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 16 papers in Environmental Chemistry and 11 papers in Cancer Research. Recurrent topics in A. MAUREEN ROUHI's work include Chemistry and Chemical Engineering (16 papers), Various Chemistry Research Topics (7 papers) and RNA Research and Splicing (7 papers). A. MAUREEN ROUHI is often cited by papers focused on Chemistry and Chemical Engineering (16 papers), Various Chemistry Research Topics (7 papers) and RNA Research and Splicing (7 papers). A. MAUREEN ROUHI collaborates with scholars based in Germany, Canada and United States. A. MAUREEN ROUHI's co-authors include Dixie L. Mager, Kristina Diepold, Ninel Azoitei, Thomas Seufferlein, Florian Kuchenbauer, Alexander Becher, Felicitas Genze, Konrad Steinestel, Thomas Simmet and R. Keith Humphries and has published in prestigious journals such as Nucleic Acids Research, Blood and The Journal of Immunology.

In The Last Decade

A. MAUREEN ROUHI

102 papers receiving 1.8k citations

Peers

Countries citing papers authored by A. MAUREEN ROUHI

Since Specialization

Citations

This map shows the geographic impact of A. MAUREEN ROUHI's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. MAUREEN ROUHI with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. MAUREEN ROUHI more than expected).

Fields of papers citing papers by A. MAUREEN ROUHI

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. MAUREEN ROUHI. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. MAUREEN ROUHI. The network helps show where A. MAUREEN ROUHI may publish in the future.

Co-authorship network of co-authors of A. MAUREEN ROUHI

This figure shows the co-authorship network connecting the top 25 collaborators of A. MAUREEN ROUHI. A scholar is included among the top collaborators of A. MAUREEN ROUHI based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. MAUREEN ROUHI. A. MAUREEN ROUHI is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elucidating the importance and regulation of key enhancers for human MEIS1 expression 2022 ·Leukemia ·Ping Xiang, (unknown), (unknown), (unknown), Edith Schneider, (unknown), Wei Wei, Jasper Wong, (unknown), (unknown), Yu Deng, Eric Yung, Gregg B. Morin, Pamela A. Hoodless, Martin Hirst, Aly Karsan, Florian Kuchenbauer, R. Keith Humphries, A. MAUREEN ROUHI	6
2	The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia 2018 ·Leukemia Research ·(unknown), Pegah Johansson, Anna Staffas, Tina Nilsson, A. MAUREEN ROUHI, Linda Fogelstrand, Lars Palmqvist	5
3	Stk33 is required for spermatid differentiation and male fertility in mice 2017 ·Developmental Biology ·Leila R. Martins, (unknown), Stefan Koch, Karsten Richter, (unknown), Dorothee Terhardt, Bahtiyar Kurtulmus, Christof Niehrs, A. MAUREEN ROUHI, Ingrid Lohmann, Gislene Pereira, Stefan Fröhling, Hanno Glimm, Claudia Scholl	19
4	Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation: A Comparison of Eculizumab Therapy and Conventional Therapy 2017 ·Biology of Blood and Marrow Transplantation ·Stephan Bohl, Florian Kuchenbauer, S. von Harsdorf, (unknown), (unknown), A. MAUREEN ROUHI, (unknown), Hartmut Döhner, Donald Bunjes, Martin Bommer	55
5	STK33 participates to HSP90-supported angiogenic program in hypoxic tumors by regulating HIF-1α/VEGF signaling pathway 2017 ·Oncotarget ·(unknown), Konrad Steinestel, A. MAUREEN ROUHI, Milena Armacki, Kristina Diepold, Gabriela Chiosis, Thomas Simmet, Thomas Seufferlein, Ninel Azoitei	17
6	MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development 2016 ·Experimental Hematology ·Edith Schneider, Anna Staffas, (unknown), (unknown), Michael Heuser, Konstanze Döhner, Lars Bullinger, Hartmut Döhner, Linda Fogelstrand, A. MAUREEN ROUHI, Florian Kuchenbauer, Lars Palmqvist	13
7	HSP90 Supports Tumor Growth and Angiogenesis through PRKD2 Protein Stabilization 2014 ·Cancer Research ·Ninel Azoitei, Kristina Diepold, Cornelia Brunner, A. MAUREEN ROUHI, Felicitas Genze, Alexander Becher, Hans A. Kestler, Johan Van Lint, Gabriela Chiosis, John Koren, Stefan Fröhling, Claudia Scholl, Thomas Seufferlein	51
8	In Search Of Good Recipes 2013 ·Chemical & Engineering News ·A. MAUREEN ROUHI	1
9	Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia 2010 ·Molecular Cancer ·Sally Rogers, Yun Zhao, Xiaoyan Jiang, Connie J. Eaves, Dixie L. Mager, A. MAUREEN ROUHI	17
10	MicroRNA-146a disrupts hematopoietic differentiation and survival 2010 ·Experimental Hematology ·Daniel T. Starczynowski, Florian Kuchenbauer, Joanna Węgrzyn, A. MAUREEN ROUHI, Oleh I. Petriv, Carl L. Hansen, R. Keith Humphries, Aly Karsan	78
11	Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1 2010 ·Experimental Hematology ·Ping Xiang, (unknown), Bob Argiropoulos, (unknown), A. MAUREEN ROUHI, Suzan Imren, Xiaoyan Jiang, Dixie L. Mager, R. Keith Humphries	20
12	Variable DNA methylation of transposable elements: The case study of mouse Early Transposons 2010 ·Epigenetics ·Daphné Reiss, Ying Zhang, A. MAUREEN ROUHI, Max Reuter, Dixie L. Mager	23
13	MiRNAs, epigenetics, and cancer 2008 ·Mammalian Genome ·A. MAUREEN ROUHI, Dixie L. Mager, R. Keith Humphries, Florian Kuchenbauer	54
14	A Role for DNA Hypomethylation and Histone Acetylation in Maintaining Allele-Specific Expression of Mouse NKG2A in Developing and Mature NK Cells 2006 ·The Journal of Immunology ·Sally Rogers, A. MAUREEN ROUHI, Fumio Takei, Dixie L. Mager	15
15	Evidence for Epigenetic Maintenance of Ly49a Monoallelic Gene Expression 2006 ·The Journal of Immunology ·A. MAUREEN ROUHI, Liane Gagnier, Fumio Takei, Dixie L. Mager	35
16	Plasticity of Ly49g expression is due to epigenetics 2006 ·Molecular Immunology ·A. MAUREEN ROUHI, Colin G. Brooks, Fumio Takei, Dixie L. Mager	10
17	CUSTOM CHEMICALS 2005 ·Chemical & Engineering News ·A. MAUREEN ROUHI	1
18	UNLOCKING THE SECRETS OF TASTE 2001 ·Chemical & Engineering News ·A. MAUREEN ROUHI	2
19	PLANTS TO THE RESCUE 1997 ·Chemical & Engineering News ·A. MAUREEN ROUHI	6
20	Researchers Unlocking Potential Of Diverse, Widely Distributed Saponins 1995 ·Chemical & Engineering News ·A. MAUREEN ROUHI	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact